SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Statement re Possible Offer

27 Mar 2009 16:28

RNS Number : 6491P
BowLeven Plc
27 March 2009
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

27 March 2009

FOR IMMEDIATE RELEASE

Bowleven plc ("Bowleven")

Update on Possible Cash Offer

On 18 March 2009, the board of directors of Bowleven announced that it had received a possible cash offer for the entire issued and to be issued share capital of the Company at a price of 150 pence per ordinary share.

The board of Bowleven has today received a revised possible offer from the potential offeror of 100 pence per ordinary share. The revised possible offer is not subject to due diligence and has received the necessary approval from the offeror's board of directors, but is subject to other customary (waivable) pre-conditions.

The board of directors of Bowleven is not aware of any reason, whether arising from the due diligence or otherwise, that would explain the difference between the offer price approved by the potential offeror's board and the indicative offer price contained in the original approach. 

The board of directors of Bowleven is currently considering the possible offer in consultation with certain major shareholders and a further update will be provided in due course.

This announcement has not been made with the agreement or approval of the potential offeror and there can be no certainty an offer will be made or as to the terms of any offer.

Enquiries:

Bowleven Plc 

Kevin Hart, Chief Executive Officer

John Brown, Finance Director

Telephone: +44 131 524 5656

Telephone: +44 131 524 5657

N M Rothschild & Sons Limited

(Financial Adviser)

Neeve Billis

James Smith

Telephone: +44 207 280 5000

Merrill Lynch International

(Financial Adviser)

Andrew Osborne

Telephone: +44 207 628 1000

Brunswick Group LLP

Patrick Handley 

Deborah Spencer

Telephone: +44 20404 5959

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of Bowleven, all "dealings" in any "relevant securities" of that company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Bowleven, they will be deemed to be a single person for the purpose of Rule 8.3. 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Bowleven by Bowleven or by any of its "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose "relevant securities" "dealings" should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at http://www.thetakeoverpanel.org.uk/new/.

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

The Directors of Bowleven accept responsibility for the information contained in this announcement. To the best of knowledge and belief of the Directors, who have taken all reasonable care to ensure such is the case, the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

N M Rothschild & Sons Limited is acting for Bowleven and no one else in connection with this matter and will not be responsible to anyone other than Bowleven for providing the protections afforded to clients of N M Rothschild & Sons Limited or for providing advice in relation to this matter.

Merrill Lynch International is acting for Bowleven and no one else in connection with the possible offer and will not be responsible to anyone other than Bowleven for providing the protections afforded to clients of Merrill Lynch International or for providing advice in relation to the possible offer.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OFDEAKDXAALNEFE
Date   Source Headline
19th Nov 20204:41 pmRNSSecond Price Monitoring Extn
19th Nov 20204:36 pmRNSPrice Monitoring Extension
16th Nov 20204:36 pmRNSAnnual Financial Report
9th Nov 20204:40 pmRNSSecond Price Monitoring Extn
9th Nov 20204:36 pmRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSBlock Admission Six Monthly Return
5th Nov 20207:00 amRNSPreliminary Results
2nd Nov 20204:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20204:36 pmRNSPrice Monitoring Extension
2nd Nov 20207:00 amRNSBoard Change
7th Oct 20207:00 amRNSNotice of Results and Corporate Update
22nd Sep 20202:35 pmRNSEmployee Benefit Trust Shares Transfer
31st Jul 20204:40 pmRNSSecond Price Monitoring Extn
31st Jul 20204:36 pmRNSPrice Monitoring Extension
15th Jun 20204:41 pmRNSSecond Price Monitoring Extn
15th Jun 20204:35 pmRNSPrice Monitoring Extension
11th May 20207:00 amRNSBlock Admission Six Monthly Return
6th May 202012:07 pmRNSSecond Price Monitoring Extn
6th May 202012:02 pmRNSPrice Monitoring Extension
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:35 pmRNSPrice Monitoring Extension
27th Mar 20207:00 amRNSInterim Results
18th Mar 20204:41 pmRNSSecond Price Monitoring Extn
18th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20206:00 pmRNSTR-1: Notification of major holdings
4th Mar 20207:00 amRNSLead FEED contract awarded for Etinde
5th Feb 20207:13 amRNSLOI signed for supply of gas from Etinde
11th Dec 201912:30 pmRNSResult of AGM
10th Dec 20194:41 pmRNSSecond Price Monitoring Extn
10th Dec 20194:35 pmRNSPrice Monitoring Extension
9th Dec 20197:00 amRNSNotice of Investor Call
29th Nov 20196:31 pmRNSPosting of Annual Report and Accounts 2019
29th Nov 20197:07 amRNSPreliminary Results Announcement
22nd Nov 20194:45 pmRNSDate of Preliminary Results announcement
18th Nov 20197:00 amRNSPosting of Notice of Annual General Meeting 2019
11th Nov 20197:00 amRNSBlock Admission Six Monthly Return
7th Jun 20199:29 amRNSChange of Adviser
9th May 20197:00 amRNSBlock Admission Six Monthly Return
1st May 20194:41 pmRNSSecond Price Monitoring Extn
1st May 20194:35 pmRNSPrice Monitoring Extension
29th Mar 20197:00 amRNSInterim Results
8th Feb 20197:00 amRNSConfirmation of Special Dividend Payment
7th Jan 20197:32 amRNSProposed Special Dividend
12th Dec 20182:19 pmRNSResult of Annual General Meeting
19th Nov 20182:20 pmRNSPosting of Annual Report and Accounts 2018
9th Nov 20187:00 amRNSBlock Admission Six Monthly Return
8th Nov 20187:00 amRNSPreliminary Results Announcement
2nd Nov 20181:43 pmRNSTR-1: Notification of major holdings
26th Oct 20187:00 amRNSNotice of Investor Call
18th Oct 20189:17 amRNSResult of IE-4 well

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.